#$%^&*AU2013203244B220161103.pdf#####Abstract In a metered dose inhaler, comprising a canister and metering valve, containing a 5 suspension aerosol formulation comprising particles of formoterol fumarate dihydrate and fluticasone propionate suspended in an HFA propellant, a method of reducing deposition of particles on the surfaces of the canister and the metering valve, the method comprising the step of adding a wetting agent to the formulation. 10 30
